Consumer Goods » Food, Beverages & Tobacco | Shengtai Pharmaceutical Inc.

Shengtai Pharmaceutical Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
115,953.90
171,717.90
179,029.10
216,450.30
221,386.70
Cost of Goods Sold (COGS) incl. D&A
98,276.20
148,594.00
161,705.20
194,450.20
202,463.90
Gross Income
17,677.80
23,123.80
17,323.90
22,000.20
18,922.80
SG&A Expense
10,281.80
9,805.00
11,825.10
14,741.80
13,192.90
EBIT
7,396.00
13,318.80
5,498.80
7,258.40
5,729.90
Non Operating Income/Expense
27.40
83.80
538.20
687.30
449.10
Interest Expense
3,660.50
3,729.40
6,079.50
7,027.90
7,275.90
Pretax Income
4,069.90
9,625.20
149.90
71.10
1,424.60
Income Tax
1,598.70
2,846.70
1.00
309.30
126.10
Equity in Affiliates
727.80
872.60
921.70
954.00
-
Consolidated Net Income
3,199.00
7,651.10
1,072.60
573.60
1,550.70
Net Income
3,199.00
7,651.10
1,072.60
573.60
1,550.70
Net Income After Extraordinaries
3,199.00
7,651.10
1,072.60
573.60
1,550.70
Net Income Available to Common
3,199.00
7,651.10
1,072.60
573.60
1,550.70
EPS (Basic)
0.34
0.80
0.11
0.06
0.16
Basic Shares Outstanding
9,584.90
9,584.90
9,584.90
9,584.90
9,584.90
EPS (Diluted)
0.33
0.80
0.11
0.06
0.16
Diluted Shares Outstanding
9,584.90
9,584.90
9,584.90
9,584.90
9,584.90
EBITDA
15,696.90
20,528.60
13,560.10
17,076.80
15,963.00
Non-Operating Interest Income
307.00
119.60
192.30
385.70
570.60

About Shengtai Pharmaceutical

View Profile
Address
Changda Road East
Changle Shandong 262400
China
Employees -
Website http://www.shengtaipharmaceutical.com
Updated 07/08/2019
Shengtai Pharmaceutical, Inc. engages in the production of pharmaceutical-grade glucose. Its products include pharmaceutical-grade glucose or dextrose, which is used for medical purposes, as well as other glucose and cornstarch products, which are used in the food and beverage industry and for industrial production. The company was founded on February 4, 1999 and is headquartered in Shandong, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.